Our focus is backing breakthrough life sciences companies. Our portfolio also includes technology businesses and venture funds we’ve partnered with along the way.
Our core focus: companies advancing cell and gene therapy, drug discovery and clinical research.
Technology and AI-enabled businesses we invested in early, and continue to support.
We’ve partnered with leading venture funds, from seed-stage specialists to growth investors, and value these long-standing relationships.
Founders and co-investors, we’d love to hear from you.
